The investor service cited publicly traded Akumin's modest scale, geographic concentration in Texas and Florida, high debt leverage, and risk tied to its "aggressive" growth strategy. 

More than 60% of recent advances could directly help patients but nearly half of all innovations would add to providers' already growing responsibilities.

"We are always looking for new ways to advance and improve patient care, and are proud to be the first center in the world to offer this novel imaging technology,” the specialist said. 

Full results of the SURPASS-1 clinical trial were presented at the American Diabetes Association’s 81st Scientific Sessions.

The feds published an updated list of nationally covered imaging indications and surprisingly excluded some scans, to providers' dismay. 

Koch Disruptive Technologies led this series C-5 effort, with others including Fidelity Management & Research Company and Baillie Gifford also chipping in.

Patients presenting with an acute myocardial infarction during the start of the COVID-19 pandemic faced delays in care and a higher risk of developing heart failure.

Physician residents and emergency care teams face higher risks of both verbal and physical assault while on the job, according to a recent study published in Annals of Emergency Medicine.

Johnson & Johnson will pay New York State $230 million in a settlement over a lawsuit against the drug manufacturer for its role in the opioid epidemic. 

Hospitals, health systems and physician groups saw big gains in May compared to the same month in 2020 when COVID-19 pandemic lockdown measures were in place.